IL120561A0 - Peptides suitable for use in immunosuppressive therapy - Google Patents

Peptides suitable for use in immunosuppressive therapy

Info

Publication number
IL120561A0
IL120561A0 IL12056197A IL12056197A IL120561A0 IL 120561 A0 IL120561 A0 IL 120561A0 IL 12056197 A IL12056197 A IL 12056197A IL 12056197 A IL12056197 A IL 12056197A IL 120561 A0 IL120561 A0 IL 120561A0
Authority
IL
Israel
Prior art keywords
immunosuppressive therapy
peptides suitable
peptides
immunosuppressive
therapy
Prior art date
Application number
IL12056197A
Other languages
English (en)
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of IL120561A0 publication Critical patent/IL120561A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL12056197A 1996-04-24 1997-03-31 Peptides suitable for use in immunosuppressive therapy IL120561A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96201106 1996-04-24

Publications (1)

Publication Number Publication Date
IL120561A0 true IL120561A0 (en) 1997-07-13

Family

ID=8223915

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12056197A IL120561A0 (en) 1996-04-24 1997-03-31 Peptides suitable for use in immunosuppressive therapy

Country Status (20)

Country Link
US (1) US6184204B1 (zh)
EP (1) EP0920451A1 (zh)
JP (1) JP2000510106A (zh)
KR (1) KR20000010561A (zh)
CN (1) CN1216551A (zh)
AR (1) AR006813A1 (zh)
AU (1) AU719481B2 (zh)
BR (1) BR9708744A (zh)
CA (1) CA2251680A1 (zh)
CZ (1) CZ340698A3 (zh)
HU (1) HUP9901375A3 (zh)
IL (1) IL120561A0 (zh)
NO (1) NO984937L (zh)
NZ (1) NZ332427A (zh)
PL (1) PL329618A1 (zh)
RU (1) RU2199548C2 (zh)
TR (1) TR199802135T2 (zh)
TW (1) TW575583B (zh)
WO (1) WO1997040068A1 (zh)
ZA (1) ZA973071B (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL345958A1 (en) * 1998-07-23 2002-01-14 Akzo Nobel Nv Novel peptides for use in immunotherapy of autoimmune diseases
MXPA02003520A (es) * 1999-10-18 2002-08-20 Akzo Nobel Nv Imitaciones de peptido y peptidos modificados para utilizarse en inmunoterapia.
IL132611A0 (en) * 1999-10-27 2001-03-19 Yeda Res & Dev Synthetic genes and polypeptides and pharmaceutical compositions comprising them
AU8125501A (en) 2000-08-14 2002-02-25 Ortho Mcneil Pharm Inc Substituted pyrazoles
US7002985B2 (en) * 2001-01-16 2006-02-21 Motorola, Inc. Method and apparatus for organizing and scheduling multimedia data transfers over a wireless channel
US7902143B2 (en) * 2004-12-07 2011-03-08 Toray Industries, Inc. Cancer antigen peptide and the use thereof
EP1856153B1 (en) * 2005-02-28 2010-12-29 Bio-Y A/S Ykl-40 monoclonal antibodies
FR2908654B1 (fr) * 2006-11-20 2014-04-04 Oreal Utilisation cosmetique de proteines de type chitinase
EP2172211B1 (en) * 2008-10-01 2014-12-03 Immatics Biotechnologies GmbH Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers
RU2008140688A (ru) * 2008-10-15 2010-04-20 Михаил Аркадьевич Шурдов (RU) Иммуносупрессивный пептид
US8557775B2 (en) 2009-06-11 2013-10-15 Yoshinori Mine Method of treating oxidative stress by administering compounds comprising serine-rich dipeptides
WO2011050471A1 (en) 2009-10-28 2011-05-05 University Of Manitoba Yellow pea seed protein-derived peptides
RU2012157597A (ru) 2010-05-31 2014-07-20 Лондон Хелс Сайенсис Сентр Рисерч Инк. Rhamm-связывающие пептиды
EP3565596A4 (en) 2017-01-05 2020-12-16 Brown University PROCESSES AND COMPOSITIONS RELATING TO ANTI-CHI3LI ANTIBODY REAGENTS
US10766968B2 (en) 2017-08-23 2020-09-08 Brown University Methods and compositions relating to anti-CHI3L1 antibody reagents to treat cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2164498C (en) 1993-07-09 2007-09-11 Paul A. Price Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices
IL115744A (en) * 1994-10-27 2000-07-16 Akzo Nobel Nv Peptides comprising a subsequence of human cartilage glycoprotein - 39

Also Published As

Publication number Publication date
TW575583B (en) 2004-02-11
HUP9901375A2 (hu) 1999-08-30
EP0920451A1 (en) 1999-06-09
CN1216551A (zh) 1999-05-12
AU719481B2 (en) 2000-05-11
NO984937D0 (no) 1998-10-23
AR006813A1 (es) 1999-09-29
TR199802135T2 (xx) 1999-01-18
WO1997040068A1 (en) 1997-10-30
NO984937L (no) 1998-12-01
NZ332427A (en) 2000-03-27
ZA973071B (en) 1998-08-05
KR20000010561A (ko) 2000-02-15
CA2251680A1 (en) 1997-10-30
BR9708744A (pt) 1999-08-03
JP2000510106A (ja) 2000-08-08
CZ340698A3 (cs) 1999-02-17
HUP9901375A3 (en) 2000-10-30
US6184204B1 (en) 2001-02-06
AU2768597A (en) 1997-11-12
RU2199548C2 (ru) 2003-02-27
PL329618A1 (en) 1999-03-29

Similar Documents

Publication Publication Date Title
PL322589A1 (en) Radiotracer-labelled peptides for use in diagnostics and therapy
HK1096974A1 (en) Antibody against human parathormone related peptides
GB9609641D0 (en) Compounds useful in therapy
AP9700923A0 (en) Triazole derivatives useful in therapy
AU3804297A (en) Chair for use in construction
IL120561A0 (en) Peptides suitable for use in immunosuppressive therapy
GB2321191B (en) Peptides for use in wound treatment
GB2316976B (en) Improvements in clamps
DE69732623D1 (en) Analogsignalmultiplexer in strombetriebsart
GB2319076B (en) Improvements in firearms
EP0951543A4 (en) HUMAN GLYCIN VECTOR
GB9604400D0 (en) Compounds useful in therapy
AU3350097A (en) Immunocontraceptive methods and peptide or polypeptides for use in these methods
GB9623551D0 (en) Improvements in hairdressing
GB9512896D0 (en) Peptides for use in vaccines
PL104533U1 (en) Cryapplicator for use in cryosurgery
GB9605904D0 (en) Peptides
GB9625227D0 (en) Peptides
GB9608430D0 (en) Peptides
GB9606765D0 (en) Peptides
SG55039A1 (en) Peptides
GB9612648D0 (en) Peptides
GB9626362D0 (en) Peptides
AU5203998A (en) Peptides for use in wound treatment
GB9612813D0 (en) Improvements in chairs